Goodbye Acne Complete Treatment Gel

Description

GOODBYE ACNE is a complete treatment gel formulated to address acne. The product is designed for topical application and is intended to provide a comprehensive solution for acne management.

Uses and Indications

This drug is indicated for the treatment and management of acne. It effectively clears up acne blemishes and blackheads while also helping to prevent the formation of new acne blemishes and blackheads.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of this product. The affected area should be covered with a thin layer of the product, applied one to three times daily.

Initial treatment should begin with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance or contact with a Poison Control center is required.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the eyes thoroughly with water to minimize potential harm.

In cases of accidental ingestion, immediate medical assistance should be sought, or patients should contact a Poison Control center without delay. Prompt action is essential to ensure patient safety.

Side Effects

Patients should be aware that this product is for external use only. The use of this medication may lead to skin irritation and dryness, particularly if it is used concurrently with another topical acne medication. In such cases, it is advised to limit the use to one topical acne treatment at a time to minimize the risk of irritation.

Additionally, care should be taken to avoid contact with the eyes. In the event of accidental contact, it is important to flush the eyes thoroughly with water to alleviate any potential discomfort or adverse effects.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the topical agents should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended during the use of this product in conjunction with other topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Goodbye Acne Complete Treatment Gel (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach, as ingestion may require immediate medical attention or contact with a Poison Control center.

For topical application, it is recommended to initiate treatment with one application daily. Dosage may be gradually increased to two to three times daily based on clinical need or physician guidance. Care should be taken to observe for excessive skin drying; if bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the prescribing information for GOODBYE ACNE Complete Treatment Gel. As such, healthcare providers should exercise caution when prescribing this treatment to geriatric patients, given the absence of targeted clinical data.

It is advisable for healthcare providers to monitor elderly patients closely for any potential adverse effects or changes in efficacy, as individual responses may vary. Further clinical evaluation may be warranted to ensure the safe and effective use of this product in the geriatric population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women should avoid the use of this product unless directed by a healthcare provider. It is essential for healthcare professionals to counsel women of childbearing potential regarding these risks and to consider alternative treatments when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control center immediately. This guidance is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from direct light exposure. To maintain the product's quality, it is essential to keep the tube tightly closed when not in use. Additionally, the product must be discarded after opening to prevent any potential degradation or contamination.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Goodbye Acne Complete Treatment Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)